Fact checked byGina Brockenbrough, MA

Read more

September 03, 2023
1 min read
Save

Enovis reports increased net sales in second-quarter 2023 financial results

Fact checked byGina Brockenbrough, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Enovis Corporation released its second-quarter 2023 financial results.
  • The company reported net sales of $429 million, an 8% increase from the prior year period.

Enovis Corporation announced net sales of $429 million in its second-quarter 2023 financial results, an 8% increase from the second quarter of 2022, according to a company press release.

Enovis reported organic sales per day growth of 9%. The company reported an 18% growth in its reconstructive segment and 4% growth in its prevention and recovery segment. According to the release, Enovis reported a second-quarter net loss from continuing operations of $15 million and adjusted earnings before interest, taxes, depreciation and amortization of $66 million.

Generic Industry News infographic

“We are pleased with our first-half 2023 results of high single-digit growth and strong margin expansion,” Matt Trerotola, CEO of Enovis, said in the release. “We continue to make progress on our strategic goals and have robust operating momentum in both of our business segments. As we look to the balance of the year, we will maintain our focus on innovation-driven share gain, operational improvement with [Enovis Growth Excellence] and compounding impact from [mergers and acquisitions],” Trerotola said.